• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ干扰素诱导的11S调节因子(PA28)以及LMP2/LMP7亚基在体外调控20S蛋白酶体的肽产生。

The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.

作者信息

Groettrup M, Ruppert T, Kuehn L, Seeger M, Standera S, Koszinowski U, Kloetzel P M

机构信息

Institute for Biochemistry, Medical Faculty (Charité), Humboldt University Berlin, Federal Republic of Germany.

出版信息

J Biol Chem. 1995 Oct 6;270(40):23808-15. doi: 10.1074/jbc.270.40.23808.

DOI:10.1074/jbc.270.40.23808
PMID:7559557
Abstract

Antigenic peptides presented on major histocompatibility complex (MHC) class I molecules to cytotoxic T cells are generated in the cytosol by the 20 S proteasome. Upon stimulation of antigen presenting cells with interferon-gamma, two constitutive subunits of the 20 S proteasome are replaced by the MHC-encoded subunits low molecular mass polypeptide (LMP) 2 and LMP 7. In addition the expression of the two subunits of the 11 S regulator of the 20 S proteasome (PA28) are increased. As the function of LMP2 and LMP7 in antigen presentation is still controversial, we tested whether these subunits might operate by modifying proteasome activation through the 11 S regulator. We strongly overexpressed the two LMP subunits separately or together by transfection in murine fibroblasts. Isolated 20 S proteasomes from LMP transfectants were applied in digests of a 25-mer peptide in the presence or absence of a purified preparation of 11 S regulator from rabbit erythrocytes. Analysis of the cleavage products by high performance liquid chromatography and electrospray mass spectroscopy revealed marked differences in the peptide product profile in dependence on the LMP2 and LMP7 content. While the 11 S regulator did not preferentially activate LMP2 or 7 containing proteasomes, the binding of the 11 S regulator to any of the proteasome preparations markedly changed both the quality and quantity of peptides produced. These results suggest that the 11 S regulator increases the spectrum of peptides which can be generated in antigen presenting cells.

摘要

主要组织相容性复合体(MHC)I类分子呈递给细胞毒性T细胞的抗原肽是由20S蛋白酶体在胞质溶胶中产生的。在用γ干扰素刺激抗原呈递细胞后,20S蛋白酶体的两个组成亚基被MHC编码的低分子量多肽(LMP)2和LMP7亚基取代。此外,20S蛋白酶体11S调节因子(PA28)的两个亚基的表达也增加。由于LMP2和LMP7在抗原呈递中的功能仍存在争议,我们测试了这些亚基是否可能通过11S调节因子来修饰蛋白酶体的激活。我们通过转染在小鼠成纤维细胞中分别或共同强烈过表达这两个LMP亚基。在存在或不存在从兔红细胞中纯化的11S调节因子制剂的情况下,将从LMP转染体中分离的20S蛋白酶体应用于25聚体肽的消化。通过高效液相色谱和电喷雾质谱对裂解产物进行分析,结果显示肽产物谱根据LMP2和LMP7的含量有显著差异。虽然11S调节因子不会优先激活含有LMP2或7的蛋白酶体,但11S调节因子与任何一种蛋白酶体制剂的结合都显著改变了产生的肽的质量和数量。这些结果表明,11S调节因子增加了抗原呈递细胞中可产生的肽的种类。

相似文献

1
The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.γ干扰素诱导的11S调节因子(PA28)以及LMP2/LMP7亚基在体外调控20S蛋白酶体的肽产生。
J Biol Chem. 1995 Oct 6;270(40):23808-15. doi: 10.1074/jbc.270.40.23808.
2
Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.蛋白酶体亚基LMP2、LMP7和MECL-1的过表达增强了免疫显性淋巴细胞性脉络丛脑膜炎病毒T细胞表位的呈递,但PA28α/β的过表达则无此作用。
J Immunol. 2000 Jul 15;165(2):768-78. doi: 10.4049/jimmunol.165.2.768.
3
Incorporation of major histocompatibility complex--encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma.主要组织相容性复合体编码的亚基LMP2和LMP7的掺入改变了20S蛋白酶体多肽加工产物的质量,且与γ干扰素无关。
Eur J Immunol. 1995 Sep;25(9):2605-11. doi: 10.1002/eji.1830250930.
4
Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7.蛋白酶体亚基X和Y对肽酶活性的影响与干扰素γ诱导的亚基LMP2和LMP7相反。
J Biol Chem. 1996 Jul 19;271(29):17275-80. doi: 10.1074/jbc.271.29.17275.
5
MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.高效抗原呈递并不需要MHC编码的蛋白酶体亚基LMP2和LMP7。
J Immunol. 1994 Feb 1;152(3):1163-70.
6
Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex.主要组织相容性复合体(MHC)编码的低分子量多肽(LMP)取代管家蛋白酶体亚基:一种调节多催化蛋白酶复合体的新发现机制。
EMBO J. 1994 Jul 15;13(14):3236-44. doi: 10.1002/j.1460-2075.1994.tb06625.x.
7
Role of proteasomes in antigen presentation.蛋白酶体在抗原呈递中的作用。
Enzyme Protein. 1993;47(4-6):354-69. doi: 10.1159/000468693.
8
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.
9
The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulated.主要组织相容性复合体编码的β型蛋白酶体亚基LMP2和LMP7。有证据表明,LMP2和LMP7以前体蛋白形式合成,且mRNA水平和含LMP的20S蛋白酶体的细胞水平受到不同调节。
Eur J Biochem. 1993 Aug 15;216(1):119-26. doi: 10.1111/j.1432-1033.1993.tb18123.x.
10
Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.蛋白酶体的肽酶活性受到主要组织相容性复合体编码的LMP2和LMP7基因的差异调节。
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9213-7. doi: 10.1073/pnas.91.20.9213.

引用本文的文献

1
Proteasome-derived peptides: separating the trash from the recycling.蛋白酶体衍生肽:区分垃圾与回收物。
Trends Biochem Sci. 2025 Jul 12. doi: 10.1016/j.tibs.2025.06.007.
2
Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.对蛋白酶体亚基β型8(PSMB8)的多方面研究为甲状腺癌的预后预测和免疫靶点提供了见解。
PLoS One. 2025 May 7;20(5):e0323013. doi: 10.1371/journal.pone.0323013. eCollection 2025.
3
Hierarchical Lineage Tracing Reveals Diverse Pathways of AML Treatment Resistance.
分层谱系追踪揭示急性髓系白血病治疗耐药的多种途径。
bioRxiv. 2025 Mar 3:2025.02.27.640600. doi: 10.1101/2025.02.27.640600.
4
Evidence of Immunoproteasome Expression Onset in the Formative State of Pluripotency in Mouse Cells.胚胎状态的小鼠细胞中免疫蛋白酶体表达的证据。
Cells. 2024 Aug 15;13(16):1362. doi: 10.3390/cells13161362.
5
The Significant Role of PA28αβ in CD8 T Cell-Mediated Graft Rejection Contrasts with Its Negligible Impact on the Generation of MHC-I Ligands.PA28αβ 在 CD8 T 细胞介导的移植物排斥反应中具有重要作用,而其对 MHC-I 配体的产生影响可以忽略不计。
Int J Mol Sci. 2024 May 22;25(11):5649. doi: 10.3390/ijms25115649.
6
Proteomic discovery of chemical probes that perturb protein complexes in human cells.蛋白质组学发现化学探针,可扰乱人细胞中的蛋白质复合物。
Mol Cell. 2023 May 18;83(10):1725-1742.e12. doi: 10.1016/j.molcel.2023.03.026. Epub 2023 Apr 20.
7
The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in cellulo.体外实验表明泛素样修饰因子 FAT10 可被 20S 蛋白酶体降解,但在细胞内却不能。
Life Sci Alliance. 2023 Apr 3;6(6). doi: 10.26508/lsa.202201760. Print 2023 Jun.
8
Inhibition of the Proteasome Regulator PA28 Aggravates Oxidized Protein Overload in the Diabetic Rat Brain.蛋白酶体调节剂 PA28 的抑制加剧了糖尿病大鼠大脑中的氧化蛋白过载。
Cell Mol Neurobiol. 2023 Aug;43(6):2857-2869. doi: 10.1007/s10571-023-01322-y. Epub 2023 Jan 30.
9
Spotlight on TAP and its vital role in antigen presentation and cross-presentation.聚焦 TAP 及其在抗原呈递和交叉呈递中的重要作用。
Mol Immunol. 2022 Feb;142:105-119. doi: 10.1016/j.molimm.2021.12.013. Epub 2021 Dec 29.
10
PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins.PA28γ-20S 蛋白酶体是一种负责降解未折叠蛋白质的蛋白水解复合物。
Cell Mol Life Sci. 2021 Dec 16;79(1):45. doi: 10.1007/s00018-021-04045-9.